|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-tropomyosin differentially affect mouse cardiac muscle contractility
1 336 Reynolds Medical Building, Cardiovascular Research Institute and Department of Medical Physiology, College of Medicine, Texas A & M University System Health Science Center, College Station, TX 77843-1114, USA
2 Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, Cincinnati, OH 45229-3039, USA
Two important charge differences between the
- and ß-tropomyosin (TM) isoforms are the exchange of a serine residue in the inner-core region at position 229, and a histidine residue at the carboxy-terminal end at position 276, with glutamic acid and asparagine, respectively. We have recently shown that altering these two residues in
-TM to their ß-TM counterparts in transgenic (TG) mouse hearts causes a depression in both +dP/dt and dP/dt and a decrease in calcium sensitivity. In this study, we address whether independent charge changes at these two residues in
-TM modulate cardiac function differentially. To test this hypothesis we generated two TG lines:
-TMSer229Glu and
-TMHis276Asn. Molecular analyses show that 98% of native
-TM is replaced by mutated protein in
-TM229 hearts whereas
-TM276 hearts show 82% replacement with the mutated protein. Isolated working heart data show that
-TM229 TG hearts exhibit a significant decrease in both +dP/dt (7%) and dP/dt (8%) compared with nontransgenics (NTGs) and time to peak pressure (TPP) is also reduced in
-TM229 hearts.
-TM276 hearts show a decrease only in dP/dt (14%) and TPP is increased. pCa2+tension relationships in skinned fibre preparations indicate decreased calcium sensitivity in
-TM229 but no change in
-TM276 preparations. Force[Ca2+]IC measurements from intact papillary fibres indicate that
-TM276 fibres produce more force per given [Ca2+]IC when compared to NTG fibres, while
-TM229 fibres produce less force per given [Ca2+]IC. These data demonstrate that changing charged residues at either the inner-core domain or the carboxyl end of TM alters sarcomeric performance differently, suggesting that the function of TM is compartmentalized along its length.
(Received 24 June 2004;
accepted after revision 13 October 2004;
first published online 14 October 2004)
Corresponding author M. Muthuchamy: 336 Reynolds Medical Building, Cardiovascular Research Institute and Department of Medical Physiology, College of Medicine, Texas A & M University System Health Science Center, College Station, TX 77843-1114, USA. Email: marim{at}tamu.edu
This article has been cited by other articles:
![]() |
R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. E. Hewett, R. Klevitsky, J. Robbins, V. Sarin, D. C. Zawieja, G. A. Meininger, and M. Muthuchamy Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H552 - H563. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sarin, R. D Gaffin, G. A Meininger, and M. Muthuchamy Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via {alpha}5{beta}1 integrin J. Physiol., April 15, 2005; 564(2): 603 - 617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |